GAPDH mediates drug resistance and metabolism in Plasmodium falciparum malaria parasites
暂无分享,去创建一个
Lisa K. McLellan | D. Hodge | Ann M. Guggisberg | A. Jezewski | A. O. Odom John | Naomi Ghebremichael | Audrey R. Odom John | Gavin Nicholas John | Dana M. Hodge
[1] G. Drewes,et al. Development of Chemical Entities Endowed with Potent Fast-Killing Properties against Plasmodium falciparum Malaria Parasites , 2019, Journal of medicinal chemistry.
[2] Anuradha Singh,et al. Glyceraldehyde-3-phosphate dehydrogenase is a chaperone that allocates labile heme in cells , 2018, The Journal of Biological Chemistry.
[3] Natasha M. Kafai,et al. Suppression of Drug Resistance Reveals a Genetic Mechanism of Metabolic Plasticity in Malaria Parasites , 2018, mBio.
[4] Neel S Madhukar,et al. A Predictive Model for Selective Targeting of the Warburg Effect through GAPDH Inhibition with a Natural Product. , 2017, Cell metabolism.
[5] D. Fidock,et al. Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic , 2017, Nature Medicine.
[6] P. So,et al. Quantification of labile heme in live malaria parasites using a genetically encoded biosensor , 2017, Proceedings of the National Academy of Sciences of the United States of America.
[7] A. Shisheva,et al. GAPDH binds Akt to facilitate cargo transport in the early secretory pathway. , 2016, Experimental cell research.
[8] M. Fay,et al. Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study. , 2016, The Lancet. Infectious diseases.
[9] J. Crowley,et al. Deconvoluting heme biosynthesis to target blood-stage malaria parasites , 2015, eLife.
[10] Christopher M. Armstrong,et al. Resistance to the Antimicrobial Agent Fosmidomycin and an FR900098 Prodrug through Mutations in the Deoxyxylulose Phosphate Reductoisomerase Gene (dxr) , 2015, Antimicrobial Agents and Chemotherapy.
[11] Christopher M. Armstrong,et al. Plasmodium IspD (2-C-Methyl-D-erythritol 4-Phosphate Cytidyltransferase), an Essential and Druggable Antimalarial Target. , 2015, ACS infectious diseases.
[12] D. Fidock,et al. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates , 2015, Science.
[13] L. Imlay,et al. Isoprenoid Metabolism in Apicomplexan Parasites , 2014, Current Clinical Microbiology Reports.
[14] Ann M. Guggisberg,et al. Isoprenoid Biosynthesis in Plasmodium falciparum , 2014, Eukaryotic Cell.
[15] D. Goldberg,et al. The peculiarities and paradoxes of Plasmodium heme metabolism. , 2014, Annual review of microbiology.
[16] D. Kwiatkowski,et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. , 2014, The New England journal of medicine.
[17] Jason W Locasale,et al. Quantitative determinants of aerobic glycolysis identify flux through the enzyme GAPDH as a limiting step , 2014, eLife.
[18] N. Tolia,et al. A sugar phosphatase regulates the methylerythritol phosphate (MEP) pathway in malaria parasites , 2014, Nature Communications.
[19] G. Biagini,et al. The proliferating cell hypothesis: a metabolic framework for Plasmodium growth and development☆ , 2014, Trends in parasitology.
[20] D. Leroy,et al. Antimalarial drug discovery – the path towards eradication , 2013, Parasitology.
[21] E. Klein. Antimalarial drug resistance: a review of the biology and strategies to delay emergence and spread. , 2013, International journal of antimicrobial agents.
[22] D. Hodge,et al. Isoprenoid Biosynthesis Inhibition Disrupts Rab5 Localization and Food Vacuolar Integrity in Plasmodium falciparum , 2012, Eukaryotic Cell.
[23] J. Dawson,et al. Heme binding properties of glyceraldehyde-3-phosphate dehydrogenase. , 2012, Biochemistry.
[24] Jun-Ping Liu,et al. GAPDH: A common enzyme with uncommon functions , 2012, Clinical and experimental pharmacology & physiology.
[25] M. V. van Hoek,et al. Resistance of Francisella Novicida to Fosmidomycin Associated with Mutations in the Glycerol-3-Phosphate Transporter , 2012, Front. Microbio..
[26] H. Boshoff,et al. Antibacterial and antitubercular activity of fosmidomycin, FR900098, and their lipophilic analogs. , 2011, Bioorganic & medicinal chemistry letters.
[27] Joseph L. DeRisi,et al. Chemical Rescue of Malaria Parasites Lacking an Apicoplast Defines Organelle Function in Blood-Stage Plasmodium falciparum , 2011, PLoS biology.
[28] K. M. Watts,et al. A second target of the antimalarial and antibacterial agent fosmidomycin revealed by cellular metabolic profiling. , 2011, Biochemistry.
[29] Shigeharu Sato,et al. The apicomplexan plastid and its evolution , 2011, Cellular and Molecular Life Sciences.
[30] A. Sawa,et al. The diverse functions of GAPDH: views from different subcellular compartments. , 2011, Cellular signalling.
[31] Ritu Chakravarti,et al. GAPDH regulates cellular heme insertion into inducible nitric oxide synthase , 2010, Proceedings of the National Academy of Sciences.
[32] S. Snyder,et al. GAPDH Mediates Nitrosylation of Nuclear Proteins , 2010, Nature Cell Biology.
[33] G. McFadden,et al. Malaria, Plasmodium falciparum and its apicoplast. , 2010, Biochemical Society transactions.
[34] N. Day,et al. Artemisinin resistance: current status and scenarios for containment , 2010, Nature Reviews Microbiology.
[35] W. V. Van Voorhis,et al. Functional genetic analysis of the Plasmodium falciparum deoxyxylulose 5-phosphate reductoisomerase gene. , 2010, Molecular and biochemical parasitology.
[36] S. Snyder,et al. Nitric oxide-induced nuclear GAPDH activates p300/CBP and mediates apoptosis , 2008, Nature Cell Biology.
[37] A. Sawa,et al. GAPDH as a sensor of NO stress. , 2006, Biochimica et biophysica acta.
[38] K. Hodgson,et al. Crystal structure of glyceraldehyde‐3‐phosphate dehydrogenase from Plasmodium falciparum at 2.25 Å resolution reveals intriguing extra electron density in the active site , 2005, Proteins.
[39] A. Bacher,et al. Biosynthesis of isoprenoids via the non-mevalonate pathway , 2004, Cellular and Molecular Life Sciences CMLS.
[40] Christopher J. Tonkin,et al. Tropical infectious diseases: Metabolic maps and functions of the Plasmodium falciparum apicoplast , 2004, Nature Reviews Microbiology.
[41] P. Coley,et al. A novel DNA-based microfluorimetric method to evaluate antimalarial drug activity. , 2004, The American journal of tropical medicine and hygiene.
[42] P. Rosenthal,et al. Antimalarial drug discovery: old and new approaches , 2003, Journal of Experimental Biology.
[43] W. Eling,et al. The N’-Terminal Domain of Glyceraldehyde-3-Phosphate Dehydrogenase of the Apicomplexan Plasmodium falciparum Mediates GTPase Rab2-Dependent Recruitment to Membranes , 2003, Biological chemistry.
[44] Leann Tilley,et al. Identification and Characterization of Heme-interacting Proteins in the Malaria Parasite, Plasmodium falciparum* , 2003, Journal of Biological Chemistry.
[45] K. Kirk,et al. Acidification of the Malaria Parasite's Digestive Vacuole by a H+-ATPase and a H+-pyrophosphatase* , 2003, The Journal of Biological Chemistry.
[46] S. Furukawa,et al. Fosmidomycin Resistance in Adenylate Cyclase Deficient (cya) Mutants of Escherichia coli , 2003, Bioscience, biotechnology, and biochemistry.
[47] S. Ralph,et al. The apicoplast as an antimalarial drug target. , 2001, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[48] P. Rangarajan,et al. Heme metabolism of Plasmodium is a major antimalarial target. , 2000, Biochemical and biophysical research communications.
[49] D. Koshland,et al. Positive and negative cooperativity in yeast glyceraldehyde 3-phosphate dehydrogenase. , 1970, Biochemistry.
[50] B. Pal. Dissection of heme binding to Plasmodium falciparum glyceraldehyde-3-phosphate dehydrogenase using spectroscopic methods and molecular docking , 2017 .
[51] D. Soldati-Favre,et al. Metabolic pathways in the apicoplast of apicomplexa. , 2010, International review of cell and molecular biology.
[52] D. Sullivan,et al. Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. , 1997, Annual review of microbiology.